New Screening Test Detects 18 Cancers Early
New Research Shows Gender-Specific Cancer Proteins, Suggesting Different Tests for Men and Women
A recent study has revealed that cancer proteins may be specific to gender, meaning that different tests may need to be developed for men and women during the diagnostic process.
The research involved the collection of blood plasma samples from 440 individuals diagnosed with 18 different types of cancer, as well as 44 healthy blood donors. The results showed that a new test was able to detect 93 percent of cancers in men and 84 percent of cancers in women at the earliest stage, with an accuracy rate of 99 percent.
According to the researchers, this test outperformed existing technologies and provided a more effective approach to the early detection of cancer. They also suggested that this discovery could lead to a reshaping of screening guidelines and that plasma testing should be made a standard part of routine check-ups.
These findings have the potential to greatly impact the way cancer is diagnosed and treated in the future. It is a significant step forward in personalized medicine and could lead to more tailored and effective treatments for both men and women.
For more updates and news on the latest research, follow NTV on social media.
